Lisa G. Horvath

Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer

Ian D. Davis, Andrew Martin, Martin R. Stockler et al. · New England Journal of Medicine · 2019 · 1.5K citations

Frequent loss of estrogen receptor-beta expression in prostate cancer.

Lisa G. Horvath, Susan M. Henshall, C S Lee et al. · PubMed · 2001 · 304 citations

Urology, Localized Pc, Medicine +9

PD-L1 expression is a favorable prognostic factor in early stage non-small cell carcinoma

Wendy A. Cooper, Trần Nam Thắng, Ricardo E. Vilain et al. · Lung Cancer · 2015 · 301 citations

Pd-l1 Expression, Favorable Prognostic Factor, Medicine +7

Report of a Multicenter Phase II Trial Testing a Combination of Biweekly Bevacizumab and Daily Erlotinib in Patients With Unresectable Biliary Cancer: A Phase II Consortium Study

Sam Joseph Lubner, Michelle R. Mahoney, J. Kolesar et al. · Journal of Clinical Oncology · 2010 · 267 citations · Full text

Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse.

Susan M. Henshall, Daniel Afar, Jordan Hiller et al. · PubMed · 2003 · 230 citations

Engineering, Tumor Biology, Trp-p8 Mrna Expression +17